Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian E Serfling

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Endocrine|February 21, 2024
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinomaWiebke Schlötelburg, Philipp E Hartrampf, Aleksander Kosmala, et al.
Cancers|February 15, 2022
Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Franz-Xaver Weinzierl, Sebastian E Serfling, et al.
Theranostics|January 8, 2025
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular riskAleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, et al.
Molecular Imaging and Biology|March 2, 2022
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersAlexander Weich, Takahiro Higuchi, Ralph A Bundschuh, et al.
Cancers|May 14, 2025
Detection of Local Prostate Cancer Recurrence from PET/CT Scans Using Deep LearningMarko Korb, Hülya Efetürk, Tim Jedamzik, et al.
Cancers|January 21, 2023
Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors-A Pan-Cancer Machine Learning Workflow for Theranostic Target StructuresAndré Marquardt, Philipp Hartrampf, Philip Kollmannsberger, et al.
Molecular Imaging and Biology|March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CTSebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
Arthritis Research & Therapy|February 11, 2026
Establishing C-X-C motif chemokine receptor 4 as a novel imaging target in giant cell arteritisMatthias Fröhlich, Sebastian E Serfling, Michael Gernert, et al.
Clinical Nuclear Medicine|March 3, 2025
Somatostatin Receptor-Directed Theranostics in EsthesioneuroblastomaYingjun Zhi, Sebastian E Serfling, Daniel Groener, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2022
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell LymphomaAndreas K Buck, Götz Ulrich Grigoleit, Sabrina Kraus, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Endocrine|February 21, 2024
Prognostic role of quantitative [18F]FDG PET/CT parameters in adrenocortical carcinomaWiebke Schlötelburg, Philipp E Hartrampf, Aleksander Kosmala, et al.
Cancers|February 15, 2022
Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Franz-Xaver Weinzierl, Sebastian E Serfling, et al.
Theranostics|January 8, 2025
C-X-C motif chemokine receptor 4-directed PET signal in the arterial tree is not consistently linked to calcified plaque burden and cardiovascular riskAleksander Kosmala, Natalie Hasenauer, Sebastian E Serfling, et al.
Molecular Imaging and Biology|March 2, 2022
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersAlexander Weich, Takahiro Higuchi, Ralph A Bundschuh, et al.
Cancers|May 14, 2025
Detection of Local Prostate Cancer Recurrence from PET/CT Scans Using Deep LearningMarko Korb, Hülya Efetürk, Tim Jedamzik, et al.
Cancers|January 21, 2023
Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors-A Pan-Cancer Machine Learning Workflow for Theranostic Target StructuresAndré Marquardt, Philipp Hartrampf, Philip Kollmannsberger, et al.
Molecular Imaging and Biology|March 21, 2022
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CTSebastian E Serfling, Constantin Lapa, Niklas Dreher, et al.
Arthritis Research & Therapy|February 11, 2026
Establishing C-X-C motif chemokine receptor 4 as a novel imaging target in giant cell arteritisMatthias Fröhlich, Sebastian E Serfling, Michael Gernert, et al.
Clinical Nuclear Medicine|March 3, 2025
Somatostatin Receptor-Directed Theranostics in EsthesioneuroblastomaYingjun Zhi, Sebastian E Serfling, Daniel Groener, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2022
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell LymphomaAndreas K Buck, Götz Ulrich Grigoleit, Sabrina Kraus, et al.
Pageof 8